Advent Bioservices vs CoJourney Inc.: CDMO Comparison

Side-by-side comparison of Advent Bioservices and CoJourney Inc. on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.

London, UK
Signal Score
78/100
Quality (FDA + GMP)
100/100
FDA inspections
0
FDA warning letters
0
EMA GMP certificates (active)
0
MHRA GMP certificates (compliant)
2
Clinical programs (matched)
0
Capacity
Modalities
AAV, Lentiviral, Adenoviral
Ambler, PA (US operations; primary manufacturing in Hangzhou, Zhejiang, China)
Signal Score
60/100
Quality (FDA + GMP)
FDA inspections
0
FDA warning letters
0
EMA GMP certificates (active)
0
MHRA GMP certificates (compliant)
0
Clinical programs (matched)
0
Capacity
Limited
Modalities
Plasmid DNA, AAV, Adenoviral, Lentiviral, Retroviral, mRNA, sgRNA, Exosome

Key differences

  • Advent Bioservices maintains 2 MHRA / UK GMP certificates; CoJourney Inc. does not.
  • Composite Signal Score: Advent Bioservices 78/100 vs CoJourney Inc. 60/100 — a 18-point gap reflecting the combined quality, capacity and financial signal.

On a 13-modality CDMO landscape, both Advent Bioservices and CoJourney Inc. qualify as AAV manufacturers; Advent Bioservices carries the higher composite Signal Score for AAV programs in this comparison.

What to evaluate for AAV programs

Both Advent Bioservices and CoJourney Inc. qualify as AAV CDMOs. When choosing between them for AAV programs, weigh these four dimensions specifically — each carries through to the side-by-side scorecard above.

Platform & scale

Suspension processes scale better than adherent (HEK293) for commercial volumes. Confirm the CDMO's largest validated bioreactor scale and serotype track record.

Capsid quality

Full/empty capsid ratio and aggregate control drive potency and safety. Ask about AUC, anion-exchange separation, and the analytics package for capsid characterization.

Regulatory readiness

For programs heading to BLA, a strong FDA inspection history and EMA/MHRA GMP coverage matter — both are shown above and on each profile.

Capacity & timelines

AAV manufacturing slots can be constrained. Weigh the capacity signal and clinical-program load before committing.

See all AAV CDMOs ranked by Signal Score →

Frequently asked: Advent Bioservices vs CoJourney Inc.

How do Advent Bioservices and CoJourney Inc. compare on European GMP coverage?

Advent Bioservices holds 0 active EMA GMP certificates and 2 MHRA / UK certificates. CoJourney Inc. holds 0 active EMA GMP certificates and 0 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.

Which is better for AAV manufacturing — Advent Bioservices or CoJourney Inc.?

Both Advent Bioservices and CoJourney Inc. are tagged as AAV CDMOs in our directory, so both are credible options for AAV programs. The most important differentiator for AAV selection is typically platform & scale: Suspension processes scale better than adherent (HEK293) for commercial volumes. Confirm the CDMO's largest validated bioreactor scale and serotype track record. Review each CDMO's profile and inspection record before shortlisting.

What does the Signal Score gap mean in practice?

Advent Bioservices carries a Signal Score of 78/100 and CoJourney Inc. carries 60/100 — a meaningful lead for Advent Bioservices. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.

Evaluating Advent Bioservices and CoJourney Inc. for a program?

Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.

Find & compare CDMOs →
Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.